from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1703c/-

LFCtreatmentdescriptionclass of inhibitor

-2.228

Amikacinug/mL Amikacintranslation

-1.582

Cap5-10ug/mL Capreomycintranslation

-2.442

Rox10-50 ug/mL Roxithromycintranslation

-0.016

SM2-5 ug/mL Streptomycintranslation

-0.986

Tet5-10 ug/mL Tetracyclinetranslation

0.206

Rif0.2-5ug/mL Rifampicintranscription

-0.180

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.043

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.389

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.734

CPZ10-50 ug/mL Chlorpromazinerespiration

0.277

Clofazimine10-13 ug/mL Clofaziminerespiration

0.594

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.878

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.888

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.778

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.844

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.330

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.878

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.976

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.373

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.850

KCN5-20 ug/mL Potassium cyaniderespiration

-0.053

NaN30.2-2 mM Sodium aziderespiration

0.630

Nigericin50 uM Nigericinrespiration

0.230

TRC10-150 ug/mL Triclosanrespiration

-0.579

TRZ10-25 ug/mL Thioridazinerespiration

-2.487

Valinomycin0.5-10 uM Valinomycinrespiration

1.449

ZnSO42 mM ZnSO4respiration

0.899

menadione6-10 ug/mL Menadionerespiration

0.058

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.675

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.383

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.946

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.422

NRP_1Non-replicating persistence stage 1dosRassociated

0.868

Amp0.2mg/mL AmpicillincellWall

0.433

Cephalexin20-100 ug/mL CephalexincellWall

0.912

Cerulenin0.32-5 ug/mL CerulenincellWall

0.419

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.370

EMB10-20 ug/mL EthambutolcellWall

0.947

Eta12-40 ug/mL EthionamidecellWall

1.497

INH0.2-0.4 ug/mL IsoniazidcellWall

0.629

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.383

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.554

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.880

BZA0.12 mg/mL BenzamidearomaticAmides

-0.857

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.929

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.037

H2O24 mM hydrogen peroxideDNAdamaging

0.241

Levo10 ug/mL LevofloxacinDNAdamaging

0.633

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.179

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.586

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.247

UVUV-irradiationDNAdamaging

-0.245

ARP41-4 ug/mL Antitubercular compound ARP4?

0.319

Antimycin12.5-50 ug/mL Antimycin A?

0.492

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.348

PA_110-50 ug/mL Antitubercular compound PA-1?

0.404

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.491

PA8240.2-2 ug/mL PA-824?

-1.425

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.162

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.557

Verapamil50 uM Verapamil?

0.182

mercaptoethanol2 mM 2-Mercaptoethanol?

0.398

methoxatin10-20 ug/mL Methoxatin?